jeff geschwind

family|hobbies|lifestyle

Follow his adventure

Dr. Jean-Francois (Jeff) Geschwind is currently the Director of Oncology at USA Vein Clinics
and USA Fibroid and Vascular Centers.

Dr. Jean-Francois (Jeff) Geschwind is currently the Director of Oncology at USA Vein Clinics and USA Fibroid and Vascular Centers where he is in charge of developing centers that provide care for cancer patients through minimally invasive procedures that are performed on an outpatient basis. Such procedures, known as interventional oncology procedures, focus on the treatment of cancer using the precision of image-guidance to treat a variety of cancers including liver, kidney, breast and lung cancers. Dr. Geschwind has devoted his career to the development of the field of interventional oncology both when he was a professor at Johns Hopkins University and then at Yale School of Medicine. Dr. Geschwind served as the first President of the Society of Interventional Oncology, a new exciting field of medicine he helped develop. These outpatient interventional oncology centers will contribute to improving the lives of thousands of cancer patients and provide such patients access to cutting edge Interventional Oncology care, provided in an outpatient setting thereby decreasing costs dramatically.

Dr. Geschwind is a highly experienced, talented and compassionate physician and extraordinary innovator. He has published almost 300 scientific manuscripts in the most highly- rated medical journals, wrote the first textbook dedicated to Interventional Oncology, created a company based on a drug he discovered while on faculty at Johns Hopkins to treat cancer and treated over 2000 patients afflicted by liver cancer in his career

Before taking on this latest professional challenge, he was Chairman of Radiology and Biomedical Imaging at the Yale School of Medicine where he was also a Professor of Radiology and Oncology and the Radiologist in Chief at Yale-New Haven Hospital. He is otherwise recognized as a key expert in the field of liver cancer worldwide and has spent years developing new therapies and diagnostic tools to help his patients.

Dr. Geschwind was born in France and studied biology and physics at the University of Paris. He then continued his studies at the University of Paris School of Medicine, followed by the pre- health program at the University of Pennsylvania. He received his medical degree from Boston University School of Medicine, then studied biological chemistry and molecular biology at the Johns Hopkins University School of Medicine. He also completed the Yale University School of Management’s Emerging Leaders program.

Dr. Geschwind completed his residency training in diagnostic radiology at the University of California San Francisco as a resident-scholar sponsored by the National Institutes of Health (NIH) , and completed his fellowship at the Johns Hopkins University School of Medicine in vascular and interventional radiology. He then joined the ranks of their faculty until being promoted to the position of Chief of Vascular and Interventional Radiology. Jeff has received numerous awards, grants, and scholarships over the years. The American Roentgen Ray Society (ARRS) awarded him a scholarship which he used to study molecular biology at Johns Hopkins. For his revolutionary work in drug delivery methods to treat liver cancer, he was recognized by the American Society of Clinical Oncology.

Dr. Geschwind has written and co-authored hundreds of articles and his research has been published in many top peer-reviewed journals, including the Journal of Clinical Oncology, Clinical Cancer Research, Cancer Research, Hepatology, Radiology, and Annals of Surgery. Dr. Geschwind also served on the editorial board of numerous journals in the field of radiology, hepatology, and oncology.

In addition to being a published author, scientist and physician, Jeff devoted a lot of his time to mentoring many medical students, residents, fellows and junior faculty members throughout his career. Most have used their experience in his research laboratory to blossom professionally and become extremely productive faculty members at prestigious institutions throughout the world. In his spare time, Jeff enjoys spending time with his family. He is passionate about soccer and is an avid fan of Ajax Amsterdam, the team he has followed since he was 7 years of age. It is perhaps not too surprising that Jeff is such an ardent supporter of Ajax as the team revolutionized the world of soccer in the 1970s through its “total football” concept made of fluidity, technical ability and perpetual movement to create space. Ajax symbolizes Jeff’s life philosophy; where innovation meets rigor. This is what he has followed throughout his scientific career. He also has a passion for Maine Coon cats. He enjoys the relaxing element they bring into his life, their gentle behavior despite their massive size, playfulness and occasionally silly behavior. They are a refreshing reminder to stop and breathe once in a while. Knowing the importance of family and friends, Jeff cherishes spending time with the people he loves and savoring such intimate moments.

Keep Checking Back for Updates!